|
|
|
Newly Passed Medicare IVIG Access Act Eases Burden of PIDD |
|
NASP - January 11, 2013 |
|
The Immune Deficiency Foundation (IDF) announced yesterday that President Obama signed into law the Medicare IVIG Access Act (HR 1845).
View
Full Article |
|
|
|
Baxter’s Gammagard Shows Alzheimer’s Benefit in Study
|
|
By Michelle Fay Cortez - Bloomberg - July 17, 2012 |
| Baxter International Inc. (BAX)’s Gammagard, used to treat immune system disorders, halted the progression of Alzheimer’s disease for as long as three years in a trial of 16 patients, researchers said.
View Full Article
|
|
|
| Gammagard therapy offers hope for Alzheimer's patients
|
|
By Janice Lloyd, USA Today |
|
Although it's still in a testing phase, the first long-term treatment shown to halt the progression of Alzheimer's disease is being hailed Tuesday by experts at the
Alzheimer's Association International Conference 2012 in Vancouver.
View
Full Article |
|
|
|
US drug shortages soar, Congressman probes "grey" marketeers
|
As the number of medicines in short supply in the US hits around 200 in 2011 so far - compared with the record 178 reported for the whole of 2010 - a leading Congressman has begun an investigation of "grey market" middleman companies, which charge exorbitant prices for prescription drugs in critically short supply.
Democratic Representative Elijah Cummings, a member of the House Committee on Oversight and Government Reform, has begun an investigation into the extent to which five such grey market companies are "making substantial profits by engaging in a form of drug speculation."
View Full Article
|
|
|